{
    "clinical_study": {
        "@rank": "117764", 
        "arm_group": [
            {
                "arm_group_label": "NHBD", 
                "description": "Non Heart Beating Donors"
            }, 
            {
                "arm_group_label": "BDD", 
                "description": "Brain death donors"
            }
        ], 
        "biospec_descr": {
            "textblock": "lung tissues and serum"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Primary graft dysfunction, a form of reperfusion pulmonary edema that occurs early after\n      lung transplantation, shares key clinical and pathological features with acute lung injury\n      and its more severe form, the acute respiratory distress syndrome. However, in contrast to\n      acute lung injury/acute respiratory distress syndrome, in which biomarkers in plasma, urine\n      and lung edema fluid have prognostic and pathogenetic value, the role of biomarkers in\n      primary graft dysfunction has been less thoroughly explored. We will try in this study de\n      determine the rule of pneumoproteins in the donor organ on the pulmonary edema in the\n      recipient."
        }, 
        "brief_title": "Pneumoproteins Expression in the Organ Donor", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Primary Graft Dysfunction", 
        "condition_browse": {
            "mesh_term": "Primary Graft Dysfunction"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        All the organ donors for lung grafts.\n\n        Exclusion Criteria:\n\n        none"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "5 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Organ donors and lung recipients"
            }
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02032069", 
            "org_study_id": "B406201112693"
        }, 
        "intervention": {
            "arm_group_label": [
                "NHBD", 
                "BDD"
            ], 
            "intervention_name": "no intervention", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 8, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Yvoir", 
                    "country": "Belgium", 
                    "state": "Namur", 
                    "zip": "5530"
                }, 
                "name": "CHU Mont-Godinne"
            }
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_groups": "2", 
        "official_title": "Pneumoproteins Expression in the Organ Donor", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Belgium: The Federal Public Service (FPS) Health, Food Chain Safety and Environment", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Number of Recipient with primary graft dysfunction", 
            "safety_issue": "No", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02032069"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital of Mont-Godinne", 
            "investigator_full_name": "Asmae Belhaj", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University Hospital of Mont-Godinne", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital of Mont-Godinne", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}